Immunoinformatics — the application of bioinformatics and computational biology to immunological research — has become an essential discipline for understanding immune system function, designing effective vaccines, predicting neoantigens for cancer immunotherapy, and analyzing immune responses at genomic scale. The COVID-19 pandemic dramatically accelerated the development and validation of computational immunology tools, demonstrating the power of immunoinformatics for rapid vaccine design and immune monitoring in unprecedented ways.

From T cell epitope prediction and MHC binding analysis to immune repertoire sequencing and neoantigen identification for personalized cancer vaccines, immunoinformatics is now at the forefront of translational immunology research. This guide covers the most important computational tools and approaches in immunoinformatics for 2026.

MHC Binding Prediction & Epitope Design

Predicting peptide binding to MHC class I and class II molecules is a fundamental challenge in computational vaccinology and cancer immunotherapy. Accurate MHC binding prediction enables rational design of T cell epitope-based vaccines and identification of immunogenic neoantigens in tumor genomes.

  • NetMHCpan — state-of-the-art pan-allele MHC class I binding prediction
  • NetMHCIIpan — MHC class II binding prediction for CD4+ T cell epitopes
  • IEDB analysis tools — comprehensive epitope prediction and analysis
  • MHCflurry — machine learning MHC-I binding affinity prediction

Neoantigen Prediction for Cancer Immunotherapy

Neoantigens — tumor-specific peptides arising from somatic mutations — are the primary targets of anti-tumor T cell responses and personalized cancer vaccines. Accurate computational prediction of immunogenic neoantigens from tumor sequencing data is critical for designing effective personalized cancer immunotherapies.

  • pVACtools — comprehensive neoantigen prediction pipeline for clinical use
  • NeoPredPipe — automated neoantigen prediction from somatic variants
  • SOPRANO — selection on passenger and driver mutations for neoantigen analysis
  • antigen.garnish — neoantigen prediction and quality filtering pipeline

Immune Repertoire Sequencing & Analysis

Immune repertoire sequencing (Rep-seq) enables comprehensive profiling of T cell receptor and B cell receptor diversity, clonal expansion, and antigen-driven selection in health, infection, and disease. Analysis of immune repertoire data provides insights into adaptive immunity, vaccine responses, and autoimmune disease mechanisms.

  • MiXCR — fast and accurate immune repertoire extraction from sequencing data
  • VDJtools — immune repertoire data analysis and visualization toolkit
  • immunarch — R package for immune repertoire analysis and visualization
  • TRUST4 — immune repertoire reconstruction from bulk RNA-seq data

Computational Vaccinology & Future Directions

Computational vaccinology integrates reverse vaccinology, structural immunology, and machine learning to design novel vaccines against infectious diseases, cancers, and other conditions. mRNA vaccine design tools developed during the COVID-19 pandemic are now being applied to personalized cancer vaccines, HIV, and other challenging targets.

The integration of single-cell transcriptomics with immune repertoire sequencing is enabling paired analysis of T cell and B cell receptor sequences alongside transcriptional profiles, providing unprecedented insights into antigen-specific immune responses at single-cell resolution.

Artificial intelligence-powered tools for predicting immunogenicity, vaccine immunogen design, and T cell cross-reactivity are rapidly advancing computational vaccinology toward more rational and effective vaccine development strategies.

Need Immunoinformatics Analysis Services?

At BioinformaticsNext, we provide expert immunoinformatics services including neoantigen prediction, MHC binding analysis, immune repertoire sequencing analysis, and computational vaccine design. Our team supports cancer immunotherapy, vaccine research, and immunology projects worldwide. Contact us today for a free consultation.